Hong Kong stocks surged | EnSilicon Intelligence (03696.HK) rose by more than 6% in early trading, the first patient treated with brain-penetrating NLRP3 inhibitors, achieving the first clinical milestone in cooperation with Hengtai Biological.

According to the Wisdom Financial News APP, British Silicon Intelligence (03696.HK) rose more than 6% in the morning session, up 4.93% as of press time, to close at 34.5 Hong Kong dollars with a trading volume of 211.58 million Hong Kong dollars.